Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders

Epigenomics

Volumn 7, Issue 7, 2015, Pages 1213-1228

  LaSalle, Janine M ^a   Reiter, Lawrence T ^b   Chamberlain, Stormy J ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Angelman syndrome; Dup15q syndrome; imprinting; neurodevelopment; proteosome; ubiquitin

Indexed keywords

HORMONE RECEPTOR; ISOPROTEIN; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3; UNTRANSLATED RNA; PROTEASOME; UBE3A PROTEIN, HUMAN; UBIQUITIN;

CELL NUCLEUS; CELLULAR DISTRIBUTION; CLINICAL FEATURE; DEVELOPMENTAL DISORDER; DUP15Q SYNDROME; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME LOCALIZATION; EPIGENETICS; GENE DUPLICATION; GENE EXPRESSION; GENE SILENCING; GENOTYPE PHENOTYPE CORRELATION; HAPPY PUPPET SYNDROME; HUMAN; MOLECULAR PATHOLOGY; MOUSE MODEL; NERVE CELL; NEURODEVELOPMENTAL DISORDER; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; REVIEW; SYNAPSE; TRANSCRIPTION REGULATION; UBIQUITIN PROTEIN LIGASE E3 DEFICIENCY; CHROMOSOME 15; FEMALE; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETICS; GENOME IMPRINTING; MALE; METABOLISM; PATHOLOGY; PROTEIN DEGRADATION; TRISOMY;

ANGELMAN SYNDROME; CELL NUCLEUS; CHROMOSOMES, HUMAN, PAIR 15; EPIGENESIS, GENETIC; FEMALE; GENOMIC IMPRINTING; HUMANS; MALE; NEURONS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STABILITY; PROTEOLYSIS; SYNAPSES; TRANSCRIPTION, GENETIC; TRISOMY; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 84949774644     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.15.70     Document Type: Review

References (112)

1. Tu Y, Chen C, Pan J, Xu J, Zhou ZG, Wang CY. The ubiquitin proteasome pathway (upp) in the regulation of cell cycle control and DNA damage repair and its implication in tumorigenesis. Int. J. Clin. Exp. Pathol. 5(8), 726-738 (2012
2. Huibregtse JM, Scheffner M, Howley PM. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol. Cell. Biol. 13(2), 775-784 (1993
3. Cooper B, Schneider S, Bohl J, Jiang Y, Beaudet A, Vande Pol S. Requirement of E6AP and the features of human papillomavirus E6 necessary to support degradation of p53. Virology 306(1), 87-99 (2003
4. Kee Y, Huibregtse JM. Regulation of catalytic activities of HECT ubiquitin ligases. Biochem. Biophys. Res. Commun. 354(2), 329-333 (2007
5. Scheffner M, Staub O. HECT E3s and human disease. BMC Biochem. 8(Suppl. 1), S6 (2007
6. Huang L, Kinnucan E, Wang G, et al. Structure of an E6APUbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade. Science 286(5443), 1321-1326 (1999
7. Ronchi VP, Klein JM, Haas AL. E6AP/UBE3A ubiquitin ligase harbors two E2 ubiquitin binding sites. J. Biol. Chem. 288(15), 10349-10360 (2013
8. Eletr ZM, Kuhlman B. Sequence determinants of E2-E6AP binding affinity and specificity. J. Mol. Biol. 369(2), 419-428 (2007
9. Ramamoorthy S, Nawaz Z. E6-associated protein (E6-AP) is a dual function coactivator of steroid hormone receptors. Nucl. Recept. Sig. 6, e006 (2008
10. Nawaz Z, Lonard DM, Smith CL, et al. The angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol. Cell. Biol. 19(2), 1182-1189 (1999
11. Nawaz Z, Lonard DM, Dennis AP, Smith CL, O'Malley BW. Proteasome-dependent degradation of the human estrogen receptor. Proc. Natl Acad. Sci. USA 96(5), 1858-1862 (1999
12. Catoe HW, Nawaz Z. E6-AP facilitates efficient transcription at estrogen responsive promoters through recruitment of chromatin modifiers. Steroids 76(9), 897-902 (2011
13. Khan OY, Fu G, Ismail A, et al. Multifunction steroid receptor coactivator, E6-associated protein, is involved in development of the prostate gland. Mol. Endocrinol. 20(3), 544-559 (2006
14. James MA, Lee JH, Klingelhutz AJ. HPV16-E6 associated hTERT promoter acetylation is E6AP dependent, increased in later passage cells and enhanced by loss of p300. Int. J. Cancer 119(8), 1878-1885 (2006
15. Jensen LJ, Farook MF, Reiter LT. Proteomic profiling in Drosophila reveals potential Dube3a regulation of the actin cytoskeleton and neuronal homeostasis. PLoS ONE 8(4), e61952 (2013
16. Ferdousy F, Bodeen W, Summers K, et al. Drosophila UBE3A regulates monoamine synthesis by increasing GTP cyclohydrolase I activity via a non-ubiquitin ligase mechanism. Neurobiol. Dis. 41(3), 669-677 (2011
17. El Hokayem J, Nawaz Z. E6AP in the brain: one protein, dual function, multiple diseases. Mol. Neurobiol. 49(2), 827-839 (2014
18. Germain ND, Chen PF, Plocik AM, et al. Gene expression analysis of human induced pluripotent stem cell-derived neurons carrying copy number variants of chromosome 15q11-q13.1. Mol. Autism 5, 44 (2014
19. Miao S, Chen R, Ye J, et al. The Angelman syndrome protein Ube3a is required for polarized dendrite morphogenesis in pyramidal neurons. J. Neurosci. 33(1), 327-333 (2013
20. Greer PL, Hanayama R, Bloodgood BL, et al. The Angelman syndrome protein Ube3a regulates synapse development by ubiquitinating arc. Cell 140(5), 704-716 (2010
21. RefSeq: NCBI. www.ncbi.nlm.nih.gov/refseq/
22. GeneCards: The Human Gene Database. www.genecards.org
23. Dindot SV, Antalffy BA, Bhattacharjee MB, et al. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum. Mol. Genet. 17(1), 111-118 (2008
24. Yashiro K, Riday TT, Condon KH, et al. Ube3a is required for experience-dependent maturation of the neocortex. Nat. Neurosci. 12(6), 777-783 (2009
25. Mabb AM, Ehlers MD. Ubiquitination in postsynaptic function and plasticity. Ann. Rev. Cell Dev. Biol. 26, 179-210 (2010
26. Valluy J, Bicker S, Aksoy-Aksel A, et al. A codingindependent function of an alternative Ube3a transcript during neuronal development. Nat. Neurosci.18(5), 666-673 (2015
27. BioGRID: results summary. http://thebiogrid.org
28. Jacobson AD, Macfadden A, Wu Z, Peng J, Liu CW. Autoregulation of the 26S proteasome by in situ ubiquitination. Mol. Biol. Cell 25(12), 1824-1835 (2014
29. Wang X, Chen CF, Baker PR, Chen PL, Kaiser P, Huang L. Mass spectrometric characterization of the affinity-purified human 26S proteasome complex. Biochemistry 46(11), 3553-3565 (2007
30. Schwarz SE, Rosa JL, Scheffner M. Characterization of human HECT domain family members and their interaction with UbcH5 and UbcH7. J. Biol. Chem. 273(20), 12148-12154 (1998
31. Ronchi VP, Klein JM, Edwards DJ, Haas AL. The active form of E6-associated protein (E6AP)/UBE3A ubiquitin ligase is an oligomer. J. Biol. Chem. 289(2), 1033-1048 (2014
32. Zaaroor-Regev D, De Bie P, Scheffner M, et al. Regulation of the polycomb protein Ring1B by self-ubiquitination or by E6-AP may have implications to the pathogenesis of angelman syndrome. Proc. Natl Acad. Sci. USA 107(15), 6788-6793 (2010
33. Kuhnle S, Kogel U, Glockzin S, et al. Physical and functional interaction of the HECT ubiquitin-protein ligases E6AP and HERC2. J. Biol. Chem. 286(22), 19410-19416 (2011
34. Nasu J, Murakami K, Miyagawa S, et al. E6AP ubiquitin ligase mediates ubiquitin-dependent degradation of peroxiredoxin 1. J. Cell. Biochem. 111(3), 676-685 (2010
35. Picard N, Charbonneau C, Sanchez M, et al. Phosphorylation of activation function-1 regulates proteasome-dependent nuclear mobility and E6-associated protein ubiquitin ligase recruitment to the estrogen receptor beta. Mol. Endocrin. 22(2), 317-330 (2008
36. Gossan NC, Zhang F, Guo B, et al. The E3 ubiquitin ligase UBE3A is an integral component of the molecular circadian clock through regulating the BMAL1 transcription factor. Nucleic Acids Res. 42(9), 5765-5775 (2014
37. Shi SQ, Bichell TJ, Ihrie RA, Johnson CH. Ube3a imprinting impairs circadian robustness in Angelman syndrome models. Curr. Biol. 25(5), 537-545 (2015
38. Margolis SS, Salogiannis J, Lipton DM, et al. EphBmediated degradation of the RhoA GEF Ephexin5 relieves a developmental brake on excitatory synapse formation. Cell 143(3), 442-455 (2010
39. Reiter LT, Seagroves TN, Bowers M, Bier E. Expression of the Rho-GEF Pbl/ECT2 is regulated by the UBE3A E3 ubiquitin ligase. Hum. Mol. Genet. 15(18), 2825-2835 (2006
40. Kumar S, Talis AL, Howley PM. Identification of HHR23A as a substrate for E6-associated protein-mediated ubiquitination. J. Biol. Chem. 274(26), 18785-18792 (1999
41. Mishra A, Godavarthi SK, Maheshwari M, Goswami A, Jana NR. The ubiquitin ligase E6-AP is induced and recruited to aggresomes in response to proteasome inhibition and may be involved in the ubiquitination of HSP70-bound misfolded proteins. J. Biol. Chem. 284(16), 10537-10545 (2009
42. Zheng L, Ding H, Lu Z, et al. E3 ubiquitin ligase E6APmediated TSC2 turnover in the presence and absence of HPV16 E6. Genes Cells 13(3), 285-294 (2008
43. Sun J, Liu Y, Moreno S, Baudry M, Bi X. Imbalanced mechanistic target of rapamycin C1 and C2 activity in the cerebellum of Angelman syndrome mice impairs motor function. J. Neurosci. 35(11), 4706-4718 (2015
44. Lee SY, Ramirez J, Franco M, et al. Ube3a, the E3 ubiquitin ligase causing angelman syndrome and linked to autism, regulates protein homeostasis through the proteasomal shuttle RPN10. Cell. Mol. Life Sci. 71(14), 2747-2758 (2014
45. Galligan JT, Martinez-Noel G, Arndt V, et al. Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. J. Proteome Res. 14(2), 953-966 (2015
46. Tan WH, Bird LM, Thibert RL, Williams CA. If not Angelman, what is it? A review of Angelman-like syndromes. Am. J. Med Genet. 164A(4), 975-992 (2014
47. Jedele KB. The overlapping spectrum of rett and angelman syndromes: a clinical review. Sem. Ped. Neurol. 14(3), 108-117 (2007
48. Thibert RL, Larson AM, Hsieh DT, Raby AR, Thiele EA. Neurologic manifestations of Angelman syndrome. Ped. Neurol. 48(4), 271-279 (2013
49. Chamberlain SJ, Lalande M. Angelman syndrome, a genomic imprinting disorder of the brain. J. Neurosci. 30(30), 9958-9963 (2010
50. Sadikovic B, Fernandes P, Zhang VW, et al. Mutation update for UBE3A variants in Angelman syndrome. Hum. Mut. 35(12), 1407-1417 (2014
51. Fang P, Lev-Lehman E, Tsai TF, et al. The spectrum of mutations in UBE3A causing Angelman syndrome. Hum. Mol. Genet. 8(1), 129-135 (1999
52. Mertz LG, Thaulov P, Trillingsgaard A, et al. Neurodevelopmental outcome in Angelman syndrome: genotype-phenotype correlations. Res. Dev. Disabil. 35(7), 1742-1747 (2014
53. Sahoo T, Peters SU, Madduri NS, et al. Microarray based comparative genomic hybridization testing in deletion bearing patients with Angelman syndrome: genotype-phenotype correlations. J. Med. Genet. 43(6), 512-516 (2006
54. Bonati MT, Russo S, Finelli P, et al. Evaluation of autism traits in angelman syndrome: a resource to unfold autism genes. Neurogenetics 8(3), 169-178 (2007
55. Peters SU, Beaudet AL, Madduri N, Bacino CA. Autism in angelman syndrome: implications for autism research. Clin. Genet. 66(6), 530-536 (2004
56. Valente KD, Fridman C, Varela MC, et al. Angelman syndrome: uniparental paternal disomy 15 determines mild epilepsy, but has no influence on EEG patterns. Epilepsy Res. 67(3), 163-168 (2005
57. Valente KD, Varela MC, Koiffmann CP, et al. Angelman syndrome caused by deletion: a genotype-phenotype correlation determined by breakpoint. Epilepsy Res. 105(1-2), 234-239 (2013
58. Mertz LG, Christensen R, Vogel I, Hertz JM, Ostergaard JR. Eating behavior, prenatal and postnatal growth in angelman syndrome. Res. Dev. Disabil. 35(11), 2681-2690 (2014
59. Brennan ML, Adam MP, Seaver LH, et al. Increased body mass in infancy and early toddlerhood in angelman syndrome patients with uniparental disomy and imprinting center defects. Am. J. Med. Genet. Part A 167A(1), 142-146 (2015
60. Hogart A, Leung KN, Wang NJ, et al. Chromosome 15q11-13 duplication syndrome brain reveals epigenetic alterations in gene expression not predicted from copy number. J. Med. Genet. 46(2), 86-93 (2009
61. UCSC Genome Browser. http://genomebrowser.wustl.edu
62. Rougeulle C, Cardoso C, Fontes M, Colleaux L, Lalande M. An imprinted antisense RNA overlaps UBE3A and a second maternally expressed transcript. Nat. Genet. 19(1), 15-16 (1998
63. Runte M, Huttenhofer A, Gross S, Kiefmann M, Horsthemke B, Buiting K. The IC-SNURF-SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3A. Hum. Mol. Genet. 10(23), 2687-2700 (2001
64. Yamasaki K, Joh K, Ohta T, et al. Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a. Hum. Mol. Genet. 12(8), 837-847 (2003
65. Meng L, Person RE, Beaud, et al. Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a. Hum. Mol. Genet. 21(13), 3001-3012 (2012
66. Sahoo T, Del Gaudio D, German JR, et al. Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat. Genet. 40(6), 719-721 (2008
67. Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader-Willi syndrome. Genet. Med. 14(1), 10-26 (2012
68. Powell WT, Coulson RL, Gonzales ML, et al. R-loop formation at Snord116 mediates topotecan inhibition of Ube3a-antisense and allele-specific chromatin decondensation. Proc. Natl Acad. Sci. USA 110(34), 13938-13943 (2013
69. Powell WT, Coulson RL, Crary FK, et al. A Prader-Willi locus lncRNA cloud modulates diurnal genes and energy expenditure. Hum. Mol. Genet. 22(21), 4318-4328 (2013
70. Vitali P, Royo H, Marty V, Bortolin-Cavaille ML, Cavaille J. Long nuclear-retained non-coding RNAs and allele-specific higher-order chromatin organization at imprinted snorna gene arrays. J. Cell. Sci. 123(Pt 1), 70-83 (2010
71. Martins-Taylor K, Hsiao JS, Chen PF, et al. Imprinted expression of UBE3A in non-neuronal cells from a Prader-Willi syndrome patient with an atypical deletion. Hum. Mol. Genet. 23(9), 2364-2373 (2014
72. Buiting K, Gross S, Lich C, Gillessen-Kaesbach G, El-Maarri O, Horsthemke B. Epimutations in Prader-Willi and Angelman syndromes: a molecular study of 136 patients with an imprinting defect. Am. J. Hum. Genet. 72(3), 571-577 (2003
73. Hiura H, Okae H, Miyauchi N, et al. Characterization of DNA methylation errors in patients with imprinting disorders conceived by assisted reproduction technologies. Hum. Reprod. 27(8), 2541-2548 (2012
74. Arnaud P, Feil R. Epigenetic deregulation of genomic imprinting in human disorders and following assisted reproduction. Birth Defects Res. 75(2), 81-97 (2005
75. Susiarjo M, Sasson I, Mesaros C, Bartolomei MS. Bisphenol a exposure disrupts genomic imprinting in the mouse. PLoS Genet. 9(4), e1003401 (2013
76. Le Meur E, Watrin F, Landers M, Sturny R, Lalande M, Muscatelli F. Dynamic developmental regulation of the large non-coding RNA associated with the mouse 7C imprinted chromosomal region. Dev. Biol. 286(2), 587-600 (2005
77. Landers M, Bancescu DL, Le Meur E, et al. Regulation of the large (approximately 1000 kb) imprinted murine Ube3a antisense transcript by alternative exons upstream of Snurf/Snrpn. Nucleic Acids Res. 32(11), 3480-3492 (2004
78. Lewis MW, Brant JO, Kramer JM, et al. Angelman syndrome imprinting center encodes a transcriptional promoter. Proc. Natl Acad. Sci. USA 112(22), 6871-6875 (2014
79. Jiang YH, Armstrong D, Albrecht U, et al. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and longterm potentiation. Neuron 21(4), 799-811 (1998
80. Yashiro K, Riday TT, Condon KH, et al. Ube3a is required for experience-dependent maturation of the neocortex. Nat. Neurosci. 12(6), 777-783 (2009
81. Miura K, Kishino T, Li E, et al. Neurobehavioral and electroencephalographic abnormalities in Ube3a maternaldeficient mice. Neurobiol. Dis. 9(2), 149-159 (2002
82. Colas D, Wagstaff J, Fort P, Salvert D, Sarda N. Sleep disturbances in Ube3a maternal-deficient mice modeling Angelman syndrome. Neurobiol. Dis. 20(2), 471-478 (2005
83. Jiang YH, Pan Y, Zhu L, et al. Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3. PLoS ONE 5(8), e12278 (2010
84. Gabriel JM, Merchant M, Ohta T, et al. A transgene insertion creating a heritable chromosome deletion mouse model of Prader-Willi and Angelman syndromes. Proc. Natl Acad. Sci. USA 96(16), 9258-9263 (1999
85. Wu MY, Chen KS, Bressler J, et al. Mouse imprinting defect mutations that model Angelman syndrome. Genesis 44(1), 12-22 (2006
86. Chamberlain SJ, Chen PF, Ng KY, et al. Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes. Proc. Natl Acad. Sci. USA 107(41), 17668-17673 (2010
87. Huang HS, Allen JA, Mabb AM, et al. Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons. Nature 481(7380), 185-189 (2012
88. King IF, Yandava CN, Mabb AM, et al. Topoisomerases facilitate transcription of long genes linked to autism. Nature 501(7465), 58-62 (2013
89. Mabb AM, Kullmann PH, Twomey MA, Miriyala J, Philpot BD, Zylka MJ. Topoisomerase 1 inhibition reversibly impairs synaptic function. Proc. Natl Acad. Sci. USA 111(48), 17290-17295 (2014
90. Meng L, Ward AJ, Chun S, Bennett CF, Beaudet AL, Rigo F. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA. Nature 518(7539), 409-412 (2015
91. Silva-Santos S, Van Woerden GM, Bruinsma CF, et al. Ube3a reinstatement identifies distinct developmental windows in a murine angelman syndrome model. J. Clin. Invest. 125(5), 2069-2076 (2015
92. Mandel-Brehm C, Salogiannis J, Dhamne SC, Rotenberg A, Greenberg ME. Seizure-like activity in a juvenile angelman syndrome mouse model is attenuated by reducing arc expression. Proc. Natl Acad. Sci. USA 112(16), 5129-5134 (2015
93. Hogart A, Wu D, Lasalle JM, Schanen NC. The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13. Neurobiol. Dis. 38(2), 181-191 (2010
94. Urraca N, Cleary J, Brewer V, et al. The interstitial duplication 15q11.2-q13 syndrome includes autism, mild facial anomalies and a characteristic EEG signature. Autism Res. 6(4), 268-279. (2013
95. Wang NJ, Parokonny AS, Thatcher KN, et al. Multiple forms of atypical rearrangements generating supernumerary derivative chromosome 15. BMC Genet. 9, 2 (2008
96. Battaglia A. The inv dup (15) or idic (15) syndrome (tetrasomy 15q). Orphanet. J. Rare Dis. 3, 30 (2008
97. Conant KD, Finucane B, Cleary N, et al. A survey of seizures and current treatments in 15q duplication syndrome. Epilepsia 55(3), 396-402 (2014
98. Noor A, Dupuis L, Mittal K, et al. 15q11.2 duplication encompassing only the Ube3a gene is associated with developmental delay and neuropsychiatric phenotypes. Hum. Mut. 36(7), 689-693 (2015
99. Cook EH Jr., Lindgren V, Leventhal BL, et al. Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am. J. Hum. Genet. 60(4), 928-934 (1997
100. Al Ageeli E, Drunat S, Delanoe C, et al. Duplication of the 15q11-q13 region: clinical and genetic study of 30 new cases. Eur. J. Med. Genet. 57(1), 5-14 (2014
101. Ogata H, Ihara H, Murakami N, Gito M, Kido Y, Nagai T. Autism spectrum disorders and hyperactive/impulsive behaviors in japanese patients with Prader-Willi syndrome: a comparison between maternal uniparental disomy and deletion cases. Am. J. Med. Genet. A 164A(9), 2180-2186 (2014
102. Dykens EM, Lee E, Roof E. Prader-Willi syndrome and autism spectrum disorders: an evolving story. J. Neurodev. Disord. 3(3), 225-237 (2011
103. Smith SE, Zhou YD, Zhang G, Jin Z, Stoppel DC, Anderson MP. Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice. Sci. Transl. Med. 3(103), 103ra197 (2011
104. Salvat C, Wang G, Dastur A, Lyon N, Huibregtse JM. The-4 phenylalanine is required for substrate ubiquitination catalyzed by HECT ubiquitin ligases. J. Biol. Chem. 279(18), 18935-18943 (2004
105. Kuhnle S, Mothes B, Matentzoglu K, Scheffner M. Role of the ubiquitin ligase E6AP/Ube3a in controlling levels of the synaptic protein arc. Proc. Natl Acad. Sci. USA 110(22), 8888-8893 (2013
106. Nakatani J, Tamada K, Hatanaka F, et al. Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism. Cell 137(7), 1235-1246 (2009
107. Meguro-Horike M, Yasui DH, Powell W, et al. Neuronspecific impairment of inter-chromosomal pairing and transcription in a novel model of human 15q-duplication syndrome. Hum. Mol. Genet. 20(19), 3798-3810 (2011
108. Brennand K, Savas JN, Kim Y, et al. Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia. Mol. Psych. 20(3), 361-368 (2014
109. Wegiel J, Frackowiak J, Mazur-Kolecka B, et al. Abnormal intracellular accumulation and extracellular abeta deposition in idiopathic and Dup15q11.2-q13 autism spectrum disorders. PLoS ONE 7(5), e35414 (2012
110. Voineagu I, Wang X, Johnston P, et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474(7351), 380-384 (2011
111. Yasui DH, Scoles HA, Horike S, et al. 15q11.2-13.3 chromatin analysis reveals epigenetic regulation of CHRNA7 with deficiencies in Rett and autism brain. Hum. Mol. Genet. 20(22), 4311-4323 (2011
112. Harlalka GV, Baple EL, Cross H, et al. Mutation of HERC2 causes developmental delay with Angelman-like features. J. Med. Genet. 50(2), 65-73 (2013